A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Flow-Tolerant Adhesion of a Bacterial Pathogen to Human Endothelial Cells Through Interaction With Biglycan




TekijätSalo Jemiina, Pietikäinen Annukka, Söderström Mirva, Auvinen Kaisa, Salmi Marko, Ebady Rhodaba, Moriarty Tara J, Viljanen Matti K, Hytönen Jukka

KustantajaOXFORD UNIV PRESS INC

Julkaisuvuosi2016

JournalJournal of Infectious Diseases

Tietokannassa oleva lehden nimiJOURNAL OF INFECTIOUS DISEASES

Lehden akronyymiJ INFECT DIS

Vuosikerta213

Numero100

Aloitussivu1623

Lopetussivu1631

Sivujen määrä9

ISSN0022-1899

eISSN1537-6613

DOIhttps://doi.org/10.1093/infdis/jiw003


Tiivistelmä
Background. Bacterial pathogens causing systemic infections disseminate from the initial infection focus to the target organs usually through the blood vasculature. To be able to colonize various organs, bacteria need to adhere to the endothelial cells of the vascular wall, and the adhesion must be strong enough to resist the shear force of the blood flow. Borrelia burgdorferi sensu lato spirochetes, the causative agents of the tick- borne disease Lyme borreliosis, disseminate hematogenously from the tick bite site to the joints, the heart, and the central nervous system of the patient.Methods.aEuro integral We used both wild-type and genetically modified B. burgdorferi s. l. bacteria, recombinant borrelia adhesins, and an array of adhesion assays carried out both under stationary and flow conditions to investigate the molecular mechanisms of borrelial adhesion to human endothelial cells.Results.aEuro integral Borrelia garinii, a member of the B. burgdorferi s. l. complex, adhered to biglycan expressed by human endothelial cells in a flow-tolerant manner. The adhesion was mediated by the decorin-binding protein A (DbpA) and DbpB surface molecules of B. garinii.Conclusions.aEuro integral The proteoglycan biglycan is a receptor molecule for flow-resistant adhesion of the bacterial pathogen B. garinii on human endothelial cells.



Last updated on 2024-26-11 at 22:55